Menu - BLL Logo

Report

April 13

Hot Topic: Data Integrity

This article takes a look at a recent FDA warning letter which highlights poor practices in relation to the integrity of electronic data. Broughton Laboratories have invested significantly in computerised systems over the past few years, not only to maintain regulatory compliance but also to provide a system (LabHQ) that add value to our clients.

The full article can be viewed here.

About the Author

Leslie Henderson was the Operations Director for Electronic Nicotine Delivery Systems (ENDS) at Broughton Laboratories. Prior to joining Broughton in 2015, Leslie served at Covance in various roles around bioanalysis and biopharmaceutical services. His educational background is a BSc in Applied Biochemistry from the University of Ulster, Jordanstown. As a member of the leadership team, Leslie brings over 16 years of experience in the drug development and biopharmaceutical industries. Since joining Broughton, Leslie’s key focus is to effectively implement strategic plans and provide diligent leadership for operational growth to meet customers’ expectations within the dynamic ENDS market.